article thumbnail

Monthly Round-Up of What to Read on Pharma Law and Policy

Bill of Health

Fulfillment of Postmarket Commitments and Requirements for New Drugs Approved by the FDA, 2013-2016. Limitations on the Capability of the FDA to Advise. Medicaid Spending on Antiretrovirals from 2007-2019. A full posting of abstracts/summaries of these articles may be found on our? JAMA Intern Med. 2022 Oct 3:e224226.

FDA 184
article thumbnail

Federal Officer Removal Fails In California

Drug & Device Law

142 (2007), mere regulation of the product or conduct at issue—the medical walker is a non-prescription, Class I medical device with general controls only—is not a basis for removal under this statute. In those cases , the question is often whether the claims put FDA compliance at issue or whether the defenses do.